陳文政
林口長庚醫院放射腫瘤科教授級主治醫師
放射腫瘤科
頭頭頸癌、鼻咽癌、大腸直腸癌、腦瘤之光子與質子治療、立體定位放射治療
教職 : 教授
醫師網路掛號
※直接點選進入醫師網路掛號畫面※語言
- 國語,英語,閩南語
現職
- 林口長庚醫院放射腫瘤科教授級主治醫師
- 長庚大學部定教授
學歷
- 1990 台北醫學院醫學士
經歷
- 2002-2014 嘉義長庚紀念醫院放射腫瘤科主任
- 2011-2013 嘉義長庚紀念醫院品管中心執行長
- 2010-2016 嘉義長庚醫院醫學倫理委員會主席
- 2011-2016. 嘉義長庚醫院人體生物資料庫倫理委員會主席
- 2011-2015. 嘉義長庚醫院醫教會副主席
- 2014-2020. 嘉義長庚醫院癌症中心主任
- 2020-2022 嘉義長庚紀念醫院放射腫瘤科主任
- 2016~ 長庚醫院學術組教授級主治醫師
- 2016~ 長庚大學部定教授
學會與認證
- 台灣放射腫瘤學會
論文及期刊發表
- Prospective Evaluation of Taste Function in Patients With Head and Neck Cancer Receiving Intensity-Modulated Radiotherapy.
- Prognostic Significance of Neoadjuvant Rectal Scores in Preoperative Short-Course Radiotherapy and Long-Course Concurrent Chemoradiotherapy for Patients with Locally Advanced Rectal Cancer.
- Treatment patterns and survival outcomes of advanced hypopharyngeal squamous cell carcinoma.
- Long-term taste impairment after intensity-modulated radiotherapy to treat head-and-neck cancer: correlations with glossectomy and the mean radiation dose to the oral cavity.
- Epigenetic therapy regulates the expression of ALDH1 and immunologic response: Relevance to the prognosis of oral cancer.
- Inflammation-induced myeloid-derived suppressor cells associated with squamous cell carcinoma of the head and neck.
- Mortality in tongue cancer patients treated by curative surgery: a retrospective cohort study from CGRD.
- Androgen deprivation increases the risk of fracture in prostate cancer patients: a population-based study in Chinese patients.
- Estimation of life expectancy and quality-adjusted life expectancy in non-metastatic nasopharyngeal cancer patients treated by intensity-modulated radiotherapy with or without chemotherapy.
- Significance of DNMT3b in oral cancer.
- Outcome of Patients with Esophageal Cancer: A Nationwide Analysis.
- Scintigraphic assessment of salivary function after intensity-modulated radiotherapy for head and neck cancer: Correlations with parotid dose and quality of life.
- Comparison of treatment results between surgery alone, preoperative short-course radiotherapy, or long-course concurrent chemoradiotherapy in locally advanced rectal cancer.
- Role of DNA methyltransferase 1 in pharyngeal cancer related to treatment resistance.
- Significance of interleukin-6 signaling in the resistance of pharyngeal cancer to irradiation and the epidermal growth factor receptor inhibitor.
- Comparison between conventional and intensity-modulated post-operative radiotherapy for stage III and IV oral cavity cancer in term of treatment results and toxicities.
- The predictive role of E2-EPF ubiquitin carrier protein in esophageal squamous cell carcinoma.
- Adjuvant concurrent chemoradiotherapy with intensity-modulated pelvic radiotherapy after surgery for high-risk, early stage cervical cancer patients.
- Clinical outcome in posthysterectomy cervical cancer patients treated with concurrent Cisplatin and intensity-modulated pelvic radiotherapy: comparison with conventional radiotherapy.
- Inhibition of lung tumor growth and augmentation of radiosensitivity by decreasing peroxiredoxin I expression.
- Differential effects of caffeic acid phenethyl ester for normal lung and lung cancer treated with irradiation: in vitro and in vivo study.
- Prediction of poor survival by cyclooxygenase-2 in patients with T4 nasopharyngeal cancer treated by radiation therapy: Clinical and in vitro studies.
- Cell killing and radiosensitization by caffeic acid phenethyl ester (CAPE) in lung cancer cells.
- The role of radiotherapy in the treatment of early stage glottic cancer.
- Concurrent cisplatin, 5-fluorouracil, leucovorin and radiotherapy for invasive bladder cancer.
- High-dose-rate sterotactic brachytherapy for patients with newly diagnosed glioblastoma multiformes
- Induction of Radioprotective peroxiredoxin-I by ionizing irradiation.
- Radiation-induced hearing impairment in patients treated for malignant parotid tumor.
- Comparison of radiotherapy and surgical results of early stage glottic cancer: a retrospective analysis.
